Virtual Network's Login.
THERE IS LESS THAN A MONTH LEFT
TO SUBMIT YOUR ABSTRACT!
PROCEED AND JOIN US IN BERLIN!
Deadline: January 2nd, 2023 (23:59 CET)
ABOUT THE CONFERENCE:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
Building on the success of our 2 previous meetings, the programme for this clinically orientated meeting will allow the attendee to be immersed in the most up-to-date information for practical management of both common and rarer scenarios across the spectrum of MPN and CML and related conditions.
Our faculty is a host of international experts who will focus their interactions around difficult clinical scenarios and there will also be a variety of case-based discussions and debates.
With its tried and tested format, this meeting has been improved for 2023 with its very clinical but cutting-edge focus. Attendees will have the opportunity to revise and discuss management with world experts and contribute to debates regarding contemporary issues.
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
This meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training
CONFERENCE SCIENTIFIC TOPICS:
• New approaches for MPNs
• CML first line therapy
• CML in advanced disease
• New drugs in CML
• Immunology, Infections in CML and MPN
• Treatment free remission
LEARNING OBJECTIVES:
Upon completion of this CME activity, participants should be able to:
• Understand and be able to deliver state of the art
management for CML and MPN
• Utilise latest information in managing patients
with therapy resistance or complications
• Consider when best to send a patient for a clinical trial
or use more conventional medication
• Have an understanding of rarer clinical conditions or clinical scenarios
THE PROGRAMME WILL INCLUDE:
Plenary Sessions - Interactive Case Presentations - Roundtables
Panel Discussions - Debates - Meet the Expert Sessions
Poster Walks - Voting technology
CLICK HERE TO ACCESS THE PRELIMINARY PROGRAMME
REGISTRATION IS OPEN: CLICK HERE
